n-vinyl-2-pyrrolidinone has been researched along with Adenocarcinoma of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Y; Kong, H; Li, X; Qi, Y; Wang, H; Xie, W; Xu, H; Zeng, X | 1 |
| Blanco, J; Domingo, JL; García, T; Gómez, M; Lafuente, D; Sánchez, DJ | 1 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Survival; Drug Carriers; Endocytosis; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Polyesters; Povidone; Solubility | 2016 |
Polyvinyl pyrrolidone-coated silver nanoparticles in a human lung cancer cells: time- and dose-dependent influence over p53 and caspase-3 protein expression and epigenetic effects.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Caspase 3; Cell Line, Tumor; Cell Survival; DNA Methylation; Dose-Response Relationship, Drug; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Lung Neoplasms; Metal Nanoparticles; Microscopy, Electron, Transmission; Povidone; Proto-Oncogene Proteins c-mdm2; Silver; Superoxide Dismutase; Tumor Suppressor Protein p53 | 2017 |